Trials / Unknown
UnknownNCT02846155
Gastric Preparation of Magnetic-controlled Capsule Endoscopy
Gastric Preparation of Magnetic-controlled Capsule Endoscopy: A Prospective, Single Blinded and Randomized Controlled Trial
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Changhai Hospital · Academic / Other
- Sex
- All
- Age
- 16 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
By using three different Gastric Preparation of Magnetic-controlled Capsule Endoscopy, the investigators hope to find out the optimal gastric preparation plan.
Detailed description
It is a prospective, single-blind, randomized controlled trial. Patients who were conducted by Magnetic-controlled Capsule Endoscopy at Changhai Hospital will be randomly allocated into three different Gastric Preparation group before the procedure. It include clear water group which patient only drink 1000ml clear water before checking; simethicone group which patient drink 950ml clear water and 15ml simethicone before checking; simethicone combined with pronase group which patient drink 900ml lear water and 15ml simethicone and 20,000iu pronase before checking. The result were got from a relevant professional physician's blinded independent image-reading.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | clear water | the patients just drink common clear water before Magnetic-controlled Capsule Endoscopy examination |
| DRUG | simethicone | the patients drink clear water and simethicone (Espumisan; Berlin-Chemie, Germany, containing 40 mg simethicone in 1 mL emulsion) before Magnetic-controlled Capsule Endoscopy examination |
| DRUG | simethicone combined with pronase | the patients drink simethicone (Espumisan; Berlin-Chemie, Germany, containing 40 mg simethicone in 1 mL emulsion),pronase granules(Deyou;Beijing Tide Pharmaceutical Co,China,containing 20,000iu pronase),and clear water before Magnetic-controlled Capsule Endoscopy examination |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2016-07-27
- Last updated
- 2016-07-27
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02846155. Inclusion in this directory is not an endorsement.